Micro Emerging Active

Dukungan FDA Alterity Therapeutics untuk Uji Coba MSA Fase 3

New narrative with limited coverage — still forming.

Skor
0,2
Kecepatan
▲ 0,0
Artikel
1
Sumber
1

Sentiment Timeline

Event Timeline

Mar 30, 2026
Alterity Therapeutics Gains FDA Backing For Phase 3 MSA Trial Neutral

Lini Waktu

Pertama TerlihatMar 30, 2026
Terakhir DiperbaruiMar 30, 2026